Browse the latest research summaries in the field of regenerative medicine & stem cells for spinal cord injury patients and caregivers.
Showing 2,281-2,290 of 2,317 results
Int. J. Mol. Sci., 2022 • October 27, 2022
Stem cell therapy is a promising treatment for SCI due to its multiple targets and reactivity benefits. Various stem cell lines can be used, each associated with specific advantages and disadvantages. I...
KEY FINDING: NSC from E14 mice on multichannel PLG scaffold increases density of axons and myelin regeneration and leads to a more rapid and functional recovery
Signal Transduction and Targeted Therapy, 2023 • July 7, 2023
This review outlines the epidemiology and pathophysiology of SCI, detailing recent progress in neural regeneration and circuit reconstruction, and suggesting future directions for SCI repair and clini...
KEY FINDING: Single-cell RNA sequencing has identified latent lineage potential in neural stem cells (NSCs) in the spinal cord's ependymal region to differentiate into oligodendrocytes by regulating OLIG2 expression.
Physiol Rep, 2018 • June 1, 2018
The study aimed to determine if spinal cord injury affects the intrinsic ability of satellite cells to differentiate and produce metabolically healthy myotubes. The results indicate that the intrinsic...
KEY FINDING: Satellite cells from spinal cord-injured individuals retain the capacity to differentiate into myotubes.
Neural Regeneration Research, 2025 • September 1, 2025
Researchers are exploring stem cell strategies, specifically transplanting hiPSC-NS/PCs into spinal cord injured tissues, with ongoing clinical trials showing promising results. HGF administration can...
KEY FINDING: HGF-induced changes in gene expression were indicative of nerve regeneration and anti-inflammatory effects, in agreement with our earlier and simpler analysis of these RNA-seq data that then mostly neglected the time course of expression
iScience, 2021 • January 22, 2021
This study uses genome-scale CRISPR screening in hPSCs to identify genes that prevent lineage specification, termed lineage-specification preventing genes (LPGs). The screening revealed that LPGs are ...
KEY FINDING: A genome-scale CRISPR screen in hPSCs identified lineage-specification preventing genes (LPGs) that, when knocked out, cause the cells to differentiate into specific germ layers.
Neural Development, 2012 • April 26, 2012
This study investigates the role of Sox2+ cells in spinal cord regeneration in Xenopus laevis tadpoles after tail amputation and spinal cord transection. The results demonstrate that spinal cord injur...
KEY FINDING: Tail amputation increases Sox2 mRNA and protein levels in the spinal cord, lateral line, and olfactory epithelium, indicating a systemic response to tissue injury.
Journal of Neuroinflammation, 2023 • October 10, 2023
This study reveals two novel normally occurring CD47-dependent mechanisms that impede myelin debris clearance by acting as a cell surface receptor. First, CD47 on Schwann cells inhibits myelin disrupt...
KEY FINDING: Myelin debris clearance, axon regeneration, and function recovery were all faster in CD47−/− mice than in wild type mice.
Frontiers in Physiology, 2015 • December 2, 2015
MSCs are considered promising for cell-based therapy due to their wide availability and resistance to malignant transformation. Despite progress, challenges remain in standardization, MSC-specific mar...
KEY FINDING: MSCs from older patients show reduced proliferative capacity, skewed differentiation potentials, telomere shortening, and DNA damage accumulation.
Stem Cell Reports, 2020 • June 9, 2020
The study identifies vascular cell adhesion molecule 1 (VCAM1) as a cell surface marker for a previously unrecognized subpopulation of neural stem cells (NSCs) in the adult mouse hippocampus. VCAM1-ex...
KEY FINDING: VCAM1 is expressed on the cell surface of qNSCs in the adult hippocampus.
Journal of Biological Chemistry, 2010 • January 8, 2010
The study identifies FM19G11 as a novel HIF inhibitor that selectively targets HIF proteins without significant cytotoxicity. FM19G11 promotes oligodendrocyte differentiation under hypoxic conditions ...
KEY FINDING: FM19G11 inhibits HIF1α and HIF2α protein accumulation in human tumor cell lines and stem cells from rodents and humans.